Citi Reiterates Buy Rating on Immunovant (IMVT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: IMVT) | Delayed: 28.41 -0.69 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.10 | 52 Week High | $ | |||
| Open | $28.93 | 52 Week Low | $ | |||
| Day High | $28.93 | P/E | N/A | |||
| Day Low | $28.14 | EPS | $ | |||
| Volume | 641,437 | |||||
